ACTRN12609001020279终止3 期
A double blinded randomised placebo controlled trial of the exelon patch (transdermal rivastigmine) for the treatment of severe delirium in elderly subacute care inpatients.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 65 Years 至 o limit（—）
- 性别
- All
入选标准
- •Severe Delirium (Confusion assessment method positive, delirium rating scale 12 or more)
排除标准
- •Informed consent unable to be obtained
- •Deficits in cardiac conducting system, resting pulse <50, intolerance or allergy to rivastigmine, carbamates or excipients.
- •Severe dysphasia, visual or hearing impairment, or non english speaking such that unable to complete scales.
- •Expected prognosis or discharge less than 2 weeks.
研究者
相似试验
尚未招募
3 期
A Randomized Double-blinded Placebo-controlled Trial of Prophylactic Rectal Indomethacin for Prevention of Post-embolization Syndrome in Patients with Hepatocellular CarcinomaPost-embolization syndromeRectal indomethacinTACEInterleukin-6Interleukin-13TNF-alphaICAM-1Hepatocellular carcinomaTCTR20210209002In process for Ratchadaphiseksomphot Endowment Fund submission120
招募中
2 期
Estradiol for the treatment of anorexia nervosaanorexia nervosaACTRN12623000897662Monash University50
招募中
Unknown
effects of melatonin as premedication agent in caesarean sectioEfficacy of melatonin to patient with caesarian section under spinal anesthesia with ASA I and ASA II.F06.4anxietyIRCT20230809059105N1Alayen universty80
进行中（未招募）
不适用
A randomised, double blind placebo controlled trial to (A) assess the optimal vitamin K dosage for supplementation, and (B) to access whether complications of anticoagulation treatment will diminish by supplementation of vitamin K: VIKS-2A / VIKS-2B. - VIKS-2A / VIKS-2BEUCTR2007-004578-15-NLDutch Heart Foundation2,600
已完成
不适用
A study of AMLA extract to assess the antioxidant and rejuvenation potential in adults in a placebo controlled clinical trial.CTRI/2018/08/015157Acara Bioherb Pvt Ltd